|
Jul 30
|
Osteosarcoma Market on the Rise in the 7MM During the Forecast Period (2025-2034) with Novel Therapeutics and Technological Innovations | DelveInsight
|
|
Jul 30
|
Madrigal buys into GLP-1 from CSPC; Apellis wins expanded drug approval
|
|
Jul 30
|
Madrigal Pharmaceuticals Enters into Exclusive Global License Agreement for Oral GLP-1 Receptor Agonist with CSPC Pharmaceutical Group Limited
|
|
Jun 30
|
Rakovina Therapeutics Highlights Strong H1 Progress and Unveils Strategic Priorities for H2 2025
|